D,
I would probably go with an allo. If you have a research protocol for NMA, or if the gent has tons of toxicities, NMA would be be fine. We would probably opt for a full with targeted bu-cy, since we (my paper, Blood) didn't show any survival difference with ages up to 65 yrs.
J
Jerald Radich, MD